Get the Stockscreener App
166.81
1.25%
-2.1056
After Hours:
167.20
0.389
+0.23%
Tradr 2 X Long Innovation 100 Monthly Etf stock is traded at $166.81, with a volume of 11,053.
It is down -1.25% in the last 24 hours and down -3.13% over the past month.
See More
Previous Close:
$168.92
Open:
$166.79
24h Volume:
11,053
Relative Volume:
1.67
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.34%
1M Performance:
-3.13%
6M Performance:
-3.23%
1Y Performance:
+45.12%
1-Day Range:
$166.56
$167.20
1-Week Range:
$166.56
$178.33
52-Week Range:
$83.00
$200.38
Tradr 2 X Long Innovation 100 Monthly Etf Stock (MQQQ) Company Profile
Name
Tradr 2 X Long Innovation 100 Monthly Etf
Sector
Industry
Phone
-
Address
-
Compare MQQQ vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MQQQ
Tradr 2 X Long Innovation 100 Monthly Etf
|
166.81 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
326.13 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
662.29 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
665.20 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
260.61 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
593.72 | 124.43B | 0 | 0 | 0 | 0.00 |
Tradr 2 X Long Innovation 100 Monthly Etf Stock (MQQQ) Latest News
EMA Aesthetics Announces Strategic Investment in MonoTx and Secures Board Representation, Advancing Regenerative Aesthetics Innovation - Barchart.com
The Best-Performing ETFs for Canadian Investors - Morningstar
Weekly ETF Industry News Recap | March 2-6, 2026 - Trackinsight
The Best-Performing ETFs for UK Investors - Morningstar Canada
Osteoarthritis Clinical Trial Pipeline Expands as 100+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
7 Best ETFs to Buy in March 2026 - The Motley Fool
Multiple Myeloma Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
This Blockchain ETF Is Quietly Becoming an AI Infrastructure Play - 24/7 Wall St.
9 Highest-Yielding Monthly Dividend Stocks for March - NerdWallet
Weekly ETF Industry News Recap | February 23-27, 2026 - Trackinsight
Vonage Brings Network Innovation to Mobile World Congress 2026 - Barchart.com
Stock List: Research Stocks from Around the World - GuruFocus
Weekly ETF Industry News Recap | February 16-20, 2026 - Trackinsight
Dan Herbatschek New York: Applied Mathematician and Technology Executive Continues to Shape Data-Driven Innovation - Barchart.com
Tradr 2X Long Innovation 100 Monthly ETF (MQQQ) Fundamental Analysis - Meyka
Hepatic Tumor Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
Western Digital Is Selling Sandisk Stock. Should You? - Barchart.com
1 Nasdaq 100 Stock for Long-Term Investors and 2 That Underwhelm - Barchart.com
7 High-Yield Covered Call ETFs Income Investors Will Love - US News Money
Ocular melanoma Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Delcath System, Aura Biosciences, Seagen, IDEAYA, Ascentage Pharma - Barchart.com
Eczema Pipeline 2026 Outlook: 100+ Clinical Assets and 3 Key Late-Stage Candidates to Watch, analyses DelveInsight - Barchart.com
Matthew Chapman – Windermere Real Estate Named #1 Real Estate Agent in Bellevue by CX Research Institute - Barchart.com
REMAX Advances Global Growth Strategy with Promotion of Chris Lim to President, Welcomes Two New Strategic Sales Leaders - Barchart.com
Coherent Corp. to Host a Technology Innovation Briefing on March 17, 2026 - Barchart.com
Tofu Market Size to Reach USD 3.77 Billion by 2031 as Flexitarian Diets and Product Innovation Accelerate Growth - Barchart.com
Cathie Wood Adds 210K Shares to a Rising AI Bet With Upside of 102% - Barchart.com
Luna Innovations IncorporatedNotice of Pendency and Proposed Settlement of Stockholder Derivative Action - Barchart.com
Symbol Lookup - GuruFocus
What is Themes Etf Trust Leverage Shares 2x Long Pltr Daily Etf’s valuation compared to sectorJuly 2025 Technicals & Free Community Supported Trade Ideas - mfd.ru
ZTS Q4 Deep Dive: Product Innovation and Competitive Pressures Shape Outlook - Barchart.com
Buy on the Dip Prospects: February 11 Edition - ETF Database
Covered Call ETF Risks Are on Full Display. Why It Might Get Much Worse. - Barchart.com
Ichthyosis Market: Rapid Increment Driven by Innovation – DelveInsight | Timber Pharma, Krystal Biotech, GSK, Timber Pharma, Janssen Scientific - Barchart.com
IgA Nephropathy Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences - Barchart.com
Diabetes Clinical Trial Pipeline Expands as 200+ Companies Driving Innovation in the Therapeutics | DelveInsight - Barchart.com
Vonage Wins Two Juniper Research Awards for Innovation in Network and Mobile Identity Solutions - Barchart.com
Tradull’s Innovative Model: Enabling Individual Participation in Global Commodities Trade - Barchart.com
QDTE: Remains A Compelling Buy With The Right Positioning (BATS:QDTE) - Seeking Alpha
7 Best Tech ETFs to Buy in 2026 | Investing - U.S. News & World Report
Is EURK benefiting from innovation trendsTrade Analysis Report & Weekly Watchlist of Top Performers - mfd.ru
Playground Play Equipment Innovation Sets New Benchmark for Safe, Engaging Spaces, Says Golden Times - Barchart.com
Orbit Capital Announces Founder First Ecosystem Supporting 45 Companies - Barchart.com
Dr. Nitun Ahir Establishes New Academic Scholarship to Foster Innovation and Strategic Leadership in Modern Medicine - Barchart.com
Global RSV Vaccines Market Set to Reach US$1.24 Billion by 2030 - Barchart.com
Cognizant and Ace Hardware Celebrate 25 Years of Partnership to Advance Next-Generation E-Commerce and Supply Chain Innovation - Barchart.com
Weekly ETF Industry News Recap | January 26-30, 2026 - Trackinsight
This Old-School Company Is Up 100% on AI Demand. Should You Buy Shares Now? - Barchart.com
Stocks Finish Mixed as Fed Keeps Interest Rates Steady - Barchart.com
Celiac Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | AMYRA Biotech AG, Equillium Bio., Chugai Pharmaceutical, Calypso Biotech - Barchart.com
Weekly ETF Industry News Recap | January 19-23, 2026 - Trackinsight
Stocks Edge Higher as Chip Makers Rally - Barchart.com
Tradr 2 X Long Innovation 100 Monthly Etf Stock (MQQQ) Financials Data
There is no financial data for Tradr 2 X Long Innovation 100 Monthly Etf (MQQQ). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.14%
1.12%
Cap:
|
Volume (24h):